Indeed, both GSK-3β overactivation and memory defects are observed in neurological disorders such as Alzheimer’s disease, Parkinson’s disease, major depression, bipolar disorders, and schizophrenia71–75. Here, GSK3B is linked to early-onset autosomal dominant Alzheimer disease.